Fig. 2

Alterations in laboratory values comparing pre- and post-treatment values in patients with integrated (n = 57) versus parallel (n = 48) CRRT-ECMO
*, p = 0.05; **, p = 0.01; ****, p ≤ 0.0001. Activated partial thromboplastin time, aPTT; continuous renal replacement therapy, CRRT; extracorporeal membrane oxygenation, ECMO; estimated glomerular filtration rate, eGFR; international normalized ratio, INR; lactate dehydrogenase, LDH; liter, L; unit, U